Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ARHGEF37 | Human | (+)-schisandrin B | multiple interactions | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGEF37 mRNA] | CTD | PMID:31150632 | ARHGEF37 | Human | 1-naphthyl isothiocyanate | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ARHGEF37 mRNA | CTD | PMID:30723492 | ARHGEF37 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:30165855 | ARHGEF37 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ARHGEF37 mRNA | CTD | PMID:31614463 | ARHGEF37 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ARHGEF37 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ARHGEF37 | Human | 2,4-dichlorophenol | increases methylation | EXP | | 6480464 | 2 and 4-dichlorophenol results in increased methylation of ARHGEF37 gene | CTD | PMID:34523531 | ARHGEF37 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ARHGEF37 mRNA | CTD | PMID:24780913 | ARHGEF37 | Human | acetamide | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of ARHGEF37 mRNA | CTD | PMID:31881176 | ARHGEF37 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ARHGEF37 mRNA | CTD | PMID:27153756 | ARHGEF37 | Human | aflatoxin B1 | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of ARHGEF37 mRNA | CTD | PMID:33354967 | ARHGEF37 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of ARHGEF37 polyA tail | CTD | PMID:30157460 | ARHGEF37 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of ARHGEF37 polyA tail | CTD | PMID:30157460 | ARHGEF37 | Human | all-trans-retinoic acid | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:36189433 | ARHGEF37 | Human | all-trans-retinoic acid | decreases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of ARHGEF37 mRNA | CTD | PMID:36189433 | ARHGEF37 | Human | amitrole | increases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of ARHGEF37 mRNA | CTD | PMID:30047161 | ARHGEF37 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ARHGEF37 mRNA | CTD | PMID:33212167 | ARHGEF37 | Human | belinostat | decreases expression | EXP | | 6480464 | belinostat results in decreased expression of ARHGEF37 mRNA | CTD | PMID:26272509 | ARHGEF37 | Human | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:27188386 | ARHGEF37 | Human | benzo[a]pyrene | increases methylation | ISO | Arhgef37 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of ARHGEF37 exon and Benzo(a)pyrene results in increased methylation of ARHGEF37 intron | CTD | PMID:27901495 | ARHGEF37 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ARHGEF37 polyA tail | CTD | PMID:30157460 | ARHGEF37 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of ARHGEF37 intron | CTD | PMID:30157460 | ARHGEF37 | Human | bisphenol A | multiple interactions | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:26496021 | ARHGEF37 | Human | bisphenol A | increases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ARHGEF37 mRNA | CTD | PMID:32156529 | ARHGEF37 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of ARHGEF37 gene | CTD | PMID:31601247 | ARHGEF37 | Human | bisphenol A | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ARHGEF37 mRNA | CTD | PMID:25181051 and PMID:30816183 | ARHGEF37 | Human | bisphenol F | increases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ARHGEF37 mRNA | CTD | PMID:38685157 | ARHGEF37 | Human | C60 fullerene | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of ARHGEF37 mRNA | CTD | PMID:19167457 | ARHGEF37 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ARHGEF37 mRNA | CTD | PMID:21592394 | ARHGEF37 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of ARHGEF37 mRNA | CTD | PMID:21592394 and PMID:26485663 | ARHGEF37 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ARHGEF37 mRNA | CTD | PMID:27392435 | ARHGEF37 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:19167446 | ARHGEF37 | Human | DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of ARHGEF37 mRNA | CTD | PMID:38568856 | ARHGEF37 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:27188386 | ARHGEF37 | Human | endosulfan | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ARHGEF37 mRNA | CTD | PMID:29391264 | ARHGEF37 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:19167446 | ARHGEF37 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of ARHGEF37 mRNA | CTD | PMID:27188386 | ARHGEF37 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ARHGEF37 protein | CTD | PMID:37730182 | ARHGEF37 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGEF37 mRNA | CTD | PMID:35811015 | ARHGEF37 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of ARHGEF37 intron | CTD | PMID:30157460 | ARHGEF37 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:36189433 | ARHGEF37 | Human | N-nitrosodiethylamine | decreases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | Diethylnitrosamine results in decreased expression of ARHGEF37 mRNA | CTD | PMID:24535843 | ARHGEF37 | Human | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of ARHGEF37 mRNA | CTD | PMID:32234424 | ARHGEF37 | Human | O-methyleugenol | increases expression | EXP | | 6480464 | methyleugenol results in increased expression of ARHGEF37 mRNA | CTD | PMID:32234424 | ARHGEF37 | Human | ozone | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARHGEF37 mRNA | CTD | PMID:27106289 | ARHGEF37 | Human | paracetamol | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ARHGEF37 mRNA | CTD | PMID:33387578 | ARHGEF37 | Human | PCB138 | multiple interactions | ISO | Arhgef37 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ARHGEF37 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ARHGEF37 mRNA | CTD | PMID:37995155 | ARHGEF37 | Human | phenobarbital | affects expression | ISO | Arhgef37 (Mus musculus) | 6480464 | Phenobarbital affects the expression of ARHGEF37 mRNA | CTD | PMID:23091169 | ARHGEF37 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGEF37 mRNA | CTD | PMID:35811015 | ARHGEF37 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:27188386 | ARHGEF37 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ARHGEF37 mRNA and Silicon Dioxide results in decreased expression of ARHGEF37 mRNA | CTD | PMID:25895662 and PMID:28425640 | ARHGEF37 | Human | sulfadimethoxine | increases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of ARHGEF37 mRNA | CTD | PMID:30047161 | ARHGEF37 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ARHGEF37 mRNA | CTD | PMID:31533062 | ARHGEF37 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ARHGEF37 mRNA | CTD | PMID:21592394 | ARHGEF37 | Human | testosterone | multiple interactions | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of ARHGEF37 mRNA | CTD | PMID:26496021 | ARHGEF37 | Human | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of ARHGEF37 mRNA | CTD | PMID:21592394 | ARHGEF37 | Human | tetrachloromethane | multiple interactions | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ARHGEF37 mRNA] | CTD | PMID:31150632 | ARHGEF37 | Human | tetrachloromethane | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ARHGEF37 mRNA | CTD | PMID:31150632 | ARHGEF37 | Human | titanium dioxide | decreases methylation | ISO | Arhgef37 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ARHGEF37 gene | CTD | PMID:35295148 | ARHGEF37 | Human | trichloroethene | decreases expression | ISO | Arhgef37 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ARHGEF37 mRNA | CTD | PMID:33387578 | ARHGEF37 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ARHGEF37 mRNA | CTD | PMID:24935251 | ARHGEF37 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of ARHGEF37 mRNA | CTD | PMID:30510588 | ARHGEF37 | Human | Triptolide | decreases expression | ISO | Arhgef37 (Mus musculus) | 6480464 | triptolide results in decreased expression of ARHGEF37 mRNA | CTD | PMID:32835833 | ARHGEF37 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ARHGEF37 mRNA | CTD | PMID:29154799 | |